Sunday, August 31, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analyst Ratings

Customers Bancorp Receives Moderate Buy Recommendation from Four Research Firms Amid Market Uncertainty

Roberto by Roberto
June 17, 2023
in Analyst Ratings
0
OKE stock news
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

As of June 16, 2023, Customers Bancorp, Inc. (NYSE:CUBI) has been assessed by four research firms and assigned an average recommendation of “Moderate Buy,” according to Bloomberg reports. The company’s shares have garnered a varied response from the analysts with one suggesting holding onto the stock while three recommend buying.

Over the past year, brokerages that issued ratings on the firm’s stock have set an average target price of $50.13 per share for the next twelve months. While fluctuations in the stock price over time cannot necessarily be equated to its true market value or potential as an investment, this estimate serves as a reference point for investors and analysts alike.

Customers Bancorp, Inc. is a financial services holding company that operates through Customers Bank, which provides consumer and commercial banking services across Pennsylvania, New York, Rhode Island, Massachusetts and Connecticut. The bank offers a range of products from checking accounts to loans aimed at small businesses and private banking services.

The financial sector is one that can be sensitive to economic changes and shifts in market trends. In today’s volatile economy where industries are challenged in unique ways by unexpected events such as global pandemics or natural disasters, it is essential that investors keep abreast of industry developments. This will enable them to make informed decisions based on market analysis and data-driven forecasts rather than reacting impulsively based on external factors alone.

It remains to be seen whether Customers Bancorp will continue its promising trajectory or experience setbacks in its growth trajectory. However, those interested in investing in the company would do well to look beyond numerical estimates and examine the underlying facets of its business model under detailed scrutiny before committing their capital resources into assets that might not return their desired yields of profit returns in this perplexing investment environment.
[bs_slider_forecast ticker=”CUBI”]

Institutional Investors Remain Steady Despite Fluctuating Ratings for Customers Bancorp

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”CUBI” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]



Customers Bancorp (CUBI), a bank holding company serving small and medium-sized businesses, has seen fluctuations in recent months as several brokerages have weighed in on its performance. On April 6th, Keefe, Bruyette & Woods decreased their price objective on CUBI shares from $51 to $45 but maintained an “outperform” rating. Maxim Group, however, lifted their price target from $40 to $45 in a report on May 1st. The divergence of opinion continued when StockNews.com initiated coverage on the stock, issuing it a “hold” rating in May. Most recently, TheStreet downgraded Customers Bancorp from a “b-” rating to “c+” in March.

These shifts in ratings may have influenced institutional investors such as Martingale Asset Management LP and Ulysses Management LLC to make adjustments to their positions within the company. Martingale Asset Management LP increased their position by 12.3% during Q3 2022, now owning 15,373 shares worth $454,000 after acquiring an additional 1,688 shares last quarter. Meanwhile, Ulysses Management LLC purchased an initial position valued at $1.18 million during Q3 2022.

Emerald Advisers LLC also grew its position by 5.6% during Q4 2022, now owning nearly 566k shares of CUBI valued at over $16 million after purchasing an additional nearly 30k shares last quarter. AlphaCrest Capital Management LLC grew its position by a significant margin of 168.8% during Q3 2022 as well with current holdings of over 33k shares valued at nearly $1 million after purchasing around another nearly 21k shares last quarter.

Kornitzer Capital Management Inc., KS also disclosed that they boosted their stake by around +21%, which brought their total investment in Customers Bancorp (CUBI) to $8.4 million worth of shares at the end of Q4 2022.

Overall, it appears that although there has been some disparity in ratings from financial analysts, institutional investors continue to hold their positions and even add to them. As June 16th, 2023 dawns, many will be watching closely to see how Customers Bancorp performs going forward and whether or not these fluctuations are just a passing trend.

Tags: CUBI
Roberto

Roberto

Related Posts

RLI stock news
Analyst Ratings

Growing Interest in Pentair plc: Institutional Investor Acquires Stake, CEO Sells Shares

September 14, 2023
SNDR stock news
Analyst Ratings

Douglass Winthrop Advisors LLC Increases Stake in Canadian National Railway as Company Announces Quarterly Dividend Increase

September 14, 2023
FITB stock news
Analyst Ratings

Investment Firm Reduces Holdings in Mettler-Toledo International Despite Strong Q2 Earnings

September 14, 2023
Next Post
BX stock news

Institutional Investor Natixis Increases Stake in DCP Midstream, LP by 120.9%

FCBC stock news

Title: Lakewood Asset Management LLC Reveals New Position in DuPont de Nemours Despite Insider Trading Reports

CSX stock news

Voya Investment Management LLC Increases Position in Datadog, Inc. by 17.8%

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Dominion Energy Stock

Dominion Energy Navigates AI-Driven Demand Surge Amid Regulatory Crosscurrents

11 hours ago
Fiserv Stock

Leadership Reshuffle at Fiserv Amidst Market Challenges

1 day ago
Pharmaceutical Market Capitalization

MindMeds MM120 Program Receives FDA Breakthrough Therapy Designation and Shows Promising Results

1 year ago
State Stock

State Street Secures Landmark Blockchain Partnership with J.P. Morgan

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAL AAPL Adobe ADSK AMD AMZN Apple AVGO BA Broadcom C Coinbase COST CRWD DIS DWAC Eli Lilly GM IBM INTC Intel Kraft Heinz LLY Lockheed META Micron MP Materials MSFT NFLX NIO NVO Opendoor Oracle Palantir PayPal PLTR Red Cat Robinhood Rocket Lab USA SMCI Strategy Tesla TGT Tilray TSLA
No Result
View All Result

Highlights

Amazon’s AI Ambitions Face Investor Scrutiny Despite Strong Earnings

Mixed Signals Cloud MaxLinear’s Outlook Despite Revenue Beat

Global Industrial Co Shares Test New Highs Amid Market Volatility

Hilltop Holdings: Strong Fundamentals Face Technical Headwinds

Fluor Shares Plummet Following Disappointing Quarterly Results

Starwood Property Faces Key Share Lockup Expiration Following Record Quarter

Trending

BridgeBio Pharma Stock
Analysis

BridgeBio’s Cardiovascular Breakthrough Fuels Investor Confidence

by Dieter Jaworski
August 31, 2025
0

BridgeBio Pharma has captured significant attention following compelling long-term data presented at the European Society of Cardiology...

CareCloud Stock

CareCloud Achieves Profit Milestone Amid Market Skepticism

August 31, 2025
Caesars Entertainmentration Stock

Caesars Entertainment Faces Divergent Fortunes in Digital and Physical Gaming Markets

August 31, 2025
Amazon Stock

Amazon’s AI Ambitions Face Investor Scrutiny Despite Strong Earnings

August 31, 2025
MaxLinear Stock

Mixed Signals Cloud MaxLinear’s Outlook Despite Revenue Beat

August 31, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • BridgeBio’s Cardiovascular Breakthrough Fuels Investor Confidence August 31, 2025
  • CareCloud Achieves Profit Milestone Amid Market Skepticism August 31, 2025
  • Caesars Entertainment Faces Divergent Fortunes in Digital and Physical Gaming Markets August 31, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com